Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer.
Cancer Gene Ther. 2022 Mar;29(3-4):369-382. doi: 10.1038/s41417-021-00317-5. Epub 2021 Mar 22.
Cancer Gene Ther. 2022.
PMID: 33753870
Clinical Trial.
Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay.
Gallion H, Christopherson WA, Coleman RL, DeMars L, Herzog T, Hosford S, Schellhas H, Wells A, Sevin BU.
Gallion H, et al.
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):194-201. doi: 10.1111/j.1525-1438.2006.00301.x.
Int J Gynecol Cancer. 2006.
PMID: 16445633
Item in Clipboard
Cite
Cite